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Abstract
Background: Methicillin resistant Staphylococcus aureus (MRSA) is a major etiological agent of infection in neonatal
intensive care units (NICUs). Routes of entry of this organism can be different and the transmission pathway complex.
Colonized neonates are the main endogenous reservoir.
Methods and Results: We conducted a prospective three-year study on MRSA colonization recruiting 722 neonates
admitted between 2009 and 2012. Nasal swabs were cultured weekly and MRSA isolates were submitted to molecular
typing. The annual incidence density of acquisition of MRSA ranged from a maximum of 20.2 cases for 1000 patient-days
during the first year to a minimum of 8.8 cases in the second one to raise again up to 13.1 cases during the third year. The
mean weekly colonization pressure fluctuated from 19.1% in the first year to 13.4% in the second year and 16.8% in the
third year. It significantly correlated with the number of MRSA acquisitions in the following week. Overall, 187 (25.9%)
subjects tested positive for MRSA. A non multiresistant, tst positive, ST22-MRSA-IVa spa t223 strain proved to be endemic in
the NICU, being identified in 166 (88.8%) out of 187 colonized neonates. Sporadic or epidemic occurrence of other strains
was detected.
Conclusions: An MRSA strain belonging to the tst1 positive, UK-EMRSA-15/ ‘‘Middle Eastern Variant’’ appeared to be
endemic in the NICU under investigation. During the three-year period, substantial changes occurred in case-mix of patients
moving towards a higher susceptibility to MRSA colonization. The infection control procedures were able to decrease the
colonization rate from more than 40% to approximately 10%, except for an outbreak due to a CA-MRSA strain, ST1-MRSA-
IVa, and a transient increase in the colonization prevalence rate coincident with a period of substantial overcrowding of the
ward. Active surveillance and molecular typing contributed to obtain a reliable picture of the MRSA dissemination in NICU.
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Introduction
Methicillin resistant Staphylococcus aureus (MRSA) is a major
etiological agent of infection in neonatal intensive care units
(NICUs) [1]. Very low birth weight (VLBW) infants and those with
serious underlying diseases, such as malformations and surgical
conditions, are generally most vulnerable to MRSA infections
[1,2]. Use of invasive devices, which is very frequent in these
patients, is also associated with increased risk for invasive MRSA
infections [3]. Routes of entry of this organism in NICU can be
different and the transmission pathway complex [2].
Colonized neonates are the main endogenous reservoir of
MRSA in NICU, but their relatives and the healthcare workers
(HCWs) may all play a role in the transmission chain [2].
Colonization pressure has also been reported as a major variable
affecting rates of MRSA acquisition [4]. Overcrowding and
understaffing have been proved to promote cross-transmission of
MRSA [5].
Clinical cultures are generally thought to underestimate MRSA
prevalence in NICU, whereas active surveillance cultures (ASCs)
are able to detect MRSA colonization and provide otherwise
unavailable information helpful to control and prevent MRSA
spread [6].
Despite NICU being a setting where healthcare associated
(HA)-MRSA clones have been frequently reported, community
associated (CA)-MRSA clones are increasingly described as
nosocomial pathogens [7]. Spread of CA-MRSA has added
further complexity to epidemiology of MRSA in NICUs as well as
to the management and control strategies of MRSA infections [2].
Molecular epidemiology can greatly contribute to address these
issues by accurately identifying MRSA clones [8].
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e87760
The purposes of this study were: a) to assess the prevalence of
MRSA colonization in infants admitted to the tertiary NICU of
the teaching hospital ‘‘P. Giaccone’’, Palermo, Italy, in the period
June 2009– June 2012; b) to identify and characterize by
molecular typing the MRSA strains circulating in the NICU; c)
to describe the temporal trend of MRSA colonization in relation to
the infection control strategies.
Methods
Study Design and Setting
This was a prospective three-year study of MRSA colonization
taking place at the tertiary NICU of the teaching hospital ‘‘Paolo
Giaccone’’, Palermo, Italy. The NICU annually admits about 250
infants of all gestational ages. Because it is associated with the
regional reference centre for genetic diseases, the NICU has a high
prevalence of neonates with malformations (20% approximately),
as well as of outborn admissions (35% approximately). Moreover,
a further 20% proportion of patients has complex conditions
requiring subspecialty medical or surgical care. The NICU
includes one intensive care room consisting of 8 cot spaces and
one intermediate care room including 8 further cot spaces. The
average nurse to patient ratio is 1:3 and 1:4 in the two sections,
respectively. The NICU ward is open to parents for 2 hours in the
morning and 4 hours in the afternoon, so that they can be
progressively involved in the general care of their child under the
guidance and supervision of the staff. Early breastfeeding is
supported.
Inclusion criteria were admission to NICU between June 16,
2009 and June 15, 2012, a hospital stay of at least 48 hours and the
collection of at least one nasal swab. Demographic, clinical and
microbiological data were prospectively collected. At admission
demographic characteristics, gestational age, birth weight, inborn
or outborn condition, delivery type, APGAR score and comorbid
Table 1. Characteristics of the patients at admission to the
NICU, June 2009–June 2012, Palermo, Italy.
Study population No. infants (%)
Gender (male) 409 (66.6)
Birth weight, g*
#1000 25 (3.5)
1001–1500 37 (5.2)
1501–2000 92 (12.8)
2001–2500 133 (18.5)
.2500 430 (60.0)
Gestational age, wk{
24–29 35 (4.9)
30–36 237 (33.2)
.36 442 (61.9)
Inborn 428 (59.3)
Age at admission .24 h 108 (14.9)
Twin birth 104 (14.4)
Cesarean delivery 490 (67.9)
Apgar score at 5 min ,8 88 (12.2)
Malformation 138 (19.1)
*information about birth weight was available for 717 out of 722 infants.
{information about gestational age was available for 714 out of 722 infants.
doi:10.1371/journal.pone.0087760.t001
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conditions were recorded. During the NICU stay, qualitative and
quantitative data were collected about the following variables:
presence of central vascular access devices, endotracheal intuba-
tion and mechanical ventilation, nasal continuous positive airway
pressure (nCPAP), peripheral catheters, type of feeding (i.e.
parenteral nutrition, enteral nutrition with oral suction or gavage,
breast milk, formula), eventual need and timing of surgery,
antibacterial drug therapy, length of stay and survival status at
discharge.
Infants were categorized as colonized by MRSA when at least
one nasal swab tested positive.
For each of the 156 weeks of the study, patient-days and patient-
days with MRSA were calculated. The mean weekly colonization
pressure (WCP) was also calculated, according with Merrer et al.
[9], as the ratio between the number of MRSA positive patient-
days in each week6 100 and the total number of patient-days in
the week.
The study protocol was approved by the Ethics Committee of
the Azienda Ospedaliero-Universitaria Policlinico ‘‘P. Giaccone’’,
Palermo, Italy, and informed consent was sought in accordance
with the principles of the Declaration of Helsinki. Written
informed consent was obtained from the parents or guardians of
the neonates.
Infection Control Strategies
Since June 2009, a surveillance protocol is routinely in place
which includes nasal and rectal swabs obtained on a weekly basis
from all infants staying in the NICU to monitor the prevalence of
carriage with MRSA, multidrug resistant (MDR) Gram negatives
and glycopeptide-resistant enterococci. Universal screening at
admission was routinely performed at the beginning of the
surveillance program, but after six months it was discontinued
because of organizational problems and a low rate of positive
culture. A policy of appropriate management of invasive devices is
well established in the NICU, including removal of central
umbilical catheter at 72 h and substitution of any further central
venous line within a maximum of 21 days and in any case of
suspected/documented blood stream infection.
Measures taken to control MRSA spread in NICU included
contact precautions, use of dedicated equipment, periodic training
sessions on hand hygiene and intensified sanitation of surfaces in
the colonized and infected neonates cot spaces. Moreover, medical
and nursing staff paid special attention to avoid overcrowding and
relative understaffing, to minimize length of hospital stay and to
promote safe use of invasive devices. Colonized and non colonized
neonates were divided in two cohorts, but without the possibility of
providing dedicated nursing staff. No neonates were treated with
mupirocin for decolonization. During the first six months of the
study, following the detection of a high prevalence of MRSA
colonization among NICU patients, surveillance cultures from
HCWs had been also performed showing a carriage prevalence of
about 8%. Nasal mupirocin treatment was administered to each
colonized HCW and decolonization was confirmed by culture of
anterior nares. Colonized staff were not furloughed, because of the
possible negative impact of understaffing on infection control
procedures.
Surveillance Cultures
Surveillance specimens from the anterior nares of neonates were
obtained with cotton swabs, immediately transferred to the
Figure 1. Prevalence of colonization by the different MRSA strains and mean weekly patient-days by quarter in the NICU under
study, June 2009–June 2012, Palermo, Italy.
doi:10.1371/journal.pone.0087760.g001
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laboratory and processed within 2 hours. Nasal swabs were
incubated overnight in Brain Hearth Infusion (BHI) broth
(OXOID, Basingstoke, UK) and then plated onto mannitol salt
agar (OXOID), incubated in air at 35uC and examined at 24 and
48 h. Presumptive S. aureus isolates were identified according to
standard methods. MRSA isolates were searched for by colony
screening onto oxacillin agar (Mueller-Hinton with oxacillin
6 mg/L). Isolates were confirmed as MRSA by the cefoxitin disk
diffusion test and PCR for detection of mecA [10].
The first isolate from each MRSA colonized patient was
submitted to genotyping and antibiotic susceptibility test. Anti-
bacterial drug susceptibility was routinely performed using the disk
diffusion method by determining the susceptibility of each isolate
to erythromycin, clindamycin, sulfamethoxazole-trimethoprim,
tetracycline, ciprofloxacin, gentamicin, tobramycin, linezolid,
rifampicin, vancomycin and teicoplanin. S. aureus ATCC 25923
was used as the quality control strain. Inducible resistance to
clindamycin was tested by ‘‘D test’’ placing a 15 mg erythromycin
disk 15 mm apart edge to edge from a 2 mg clindamycin disk on
a Mueller-Hinton agar plate previously inoculated with an
MRSA isolate. A D-shape of the zone around clindamycin
facing the erythromycin disk indicated inducible clindamycin
resistance. Results were interpreted using the European Commit-
tee on Antimicrobial Susceptibility Testing (EUCAST) clinical
breakpoints (http://www.eucast.org/fileadmin/src/media/PDFs/
EUCAST_files/Breakpoint_tables/).
Molecular Typing
Staphylococcal cassette chromosome (SCC) mec was typed by
the multiplex PCR method described by Milheiric¸o et al. [11].
Genotypic characterization of the MRSA isolates was performed
by multilocus variable number tandem repeat fingerprinting
(MLVF) [12]. Gel images were stored as TIFF files. Banding
patterns were analyzed both visually and by using Bionumerics
version 5.10 (Applied Maths, Sint-Martens-Latem, Belgium).
The S. aureus Genotyping Kit (Alere Technologies, Jena,
Germany) was used for DNA microarray analysis on 10
representative isolates of the different MLVF patterns of ST22-
IVa at the National Center for Antimicrobials and Infection
Control, Statens Serum Institut, Copenhagen, Denmark. This kit
allows for detection of 334 S. aureus gene sequences, including
species-specific, antimicrobial resistance, and virulence genes as
well as typing markers. The DNA microarray protocol was
performed according to the manufacturer’s instructions. Data
generated by the S. aureus genotyping kit arrays were analyzed
using the Arraymate software (Alere Technologies), which assigns
MRSA isolates to STs and/or clonal complexes (CCs) by
comparing each isolate’s profile to those of a collection of
previously characterized strains in the Arraymate database [13].
Fifteen representative strains of all the different MLVF patterns
were also analyzed by multilocus sequence typing (MLST). The
MLST allelic profiles and sequence types were assigned by
submission to the S. aureus MLST database (www.mlst.net).
Additionally, spa typing was carried out, as previously described,
on eight ST22-MRSA-IVa isolates representative of the different
MLVF patterns [14]. The spa type was determined using the
Ridom StaphType software (http://www.ridom.de/staphtype/).
Statistical Analysis
Analysis of the variance (ANOVA) was carried out for
comparing mean values differences between the three year-periods
of the study. The Bonferroni pairwise procedure was adopted as
post-hoc test. Correlation between the mean WCP values and the
Table 3. Molecular characteristics, antibacterial drug resistance pattern and time of isolation of isolates belonging to the different
clones.
Sequence type SCC-mec type MLVF No. of isolates Antimicrobial susceptibility pattern Quarter
Cip Cli Ery Gen Lin Rif Sxt Tec Tet Tob Va
22 IVa 22-A 67 S S S S S S S S S S S 1–12
22 IVa 22-A 67 S S S S S S S S R S S 1–12
22 IVa 22-B 4 S S S S S S S S S S S 2,4
22 IVa 22-C 17 S S S S S S S S R S S 2,3
22 IVa 22-D 2 S S S S S S S S R S S 8
22 IVa 22-E 1 S S S S S S S S R S S 8
22 IVa 22-F 1 S S S S S S S S R S S 9
22 IVa 22-F 1 S S S S S S S S S S S 9
22 IVa 22-H 4 S S S S S S S S S S S 10
22 IVa 22-I 2 S S S S S S S S S S S 11
8 IVa 8-A 1 R S R S S S S S S S S 5
1 IVa 1-A 15 S S* R R S S S S S S S 8,9
7 IVa 7-A 1 S S S S S S S S R S S 10
20 IVa 20-A 1 S S R S S S S S R S S 1
45 IVa 45-A, 45-B 2 S S S R S S S S S S S 5,9
97 IVa 97-A 1 S S S R S S S S R S S 5
SCC-mec, staphylococcal cassette chromosome mec; MLVF, multilocus variable number tandem repeat fingerprinting; S, susceptible; R, resistant.
Cip, ciprofloxacin; Cli, clindamycin; Ery, erythromycin; Gen, gentamicin; Lin, linezolid; Rif, rifampicin; Sxt, sulfamethoxazole-trimethoprim; Tec, teicoplanin; Tet,
tetracycline; Tob, tobramycin; Va, vancomycin.
*Inducible clindamycin-resistant phenotype.
doi:10.1371/journal.pone.0087760.t003
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number of incident MRSA colonizations in the immediately
following week was analysed using least-square linear regression.
The characteristics of the neonates with and without MRSA
colonization as well as neonates with colonization with ST22-IVa
and other MRSA strains were compared by calculating the means
(standard deviation, SD) and frequencies. The significance of
differences was assessed by one-way ANOVA test or Kruskall-
Wallis, when appropriate, or by the chi-square test or the Fisher’s
exact test, respectively. All reported P values were two-sided and
p,0.05 was considered significant. Statistical analysis was
performed by using EpiInfo (version 7; CDC, Atlanta, GA, US)
and STATA MP, v. 11.0.
Results
During the study period, 722 infants fulfilling the inclusion
criteria were admitted to the NICU and enrolled into the study.
Their main characteristics are summarized in Table 1.
The annual outborn proportion of admissions raised from
30.8% to 32.9% and to 36.3%, although the increase was not
statistically significant (P 0.09). Meanwhile, gestational age proved
to gradually decrease from a mean of 37.0 weeks (median 38.0
weeks, interquartile range [IQR] 36.0–39.5 weeks) in the first year
to 36.6 weeks (median 37.0 weeks, IQR 35.5–39.1 weeks) in the
second year and to 36.2 weeks (median 37.0 weeks, IQR 34.5–
39.0 weeks) in the third year (ANOVA, F=7.69; Bonferroni test:
first and second year, P 0.85; first and third year, P,0.001; second
and third year, P 0.02).
The average length of stay was 18.9 days (median 11 days, IQR
7–22 days). Over the study period the median length significantly
increased up to 14 days, IQR 8–26 days, in the third year from 9,
IQR 7–22 days, in the first year and 10, IQR 7.5–18.5 days, in the
second year (ANOVA, F= 3.61; Bonferroni test: first and second
year, P 0.91; first and third year, P 0.02; second and third year, P
0.02). The mean number of patient-days by week increased also
over the study period from 65.1617.1 during the first year to
68.0614.4 during the second year and 82.1616.1 during the third
year (ANOVA, F= 16.96; Bonferroni test: first and second year, P
0.89; first and third year, P,0.001; second and third year,
P,0.001) (Table 2).
Three hundred eighty (52.7%) infants received some antibiotic
treatment during the NICU stay. Ampicillin-sulbactam and
gentamicin were the most commonly used antimicrobials, being
administered to 339 (89.2%) out of these patients for a mean of 3.3
days (median 3 days, IQR 1–5 days). A total of 2028 nasal swabs
were cultured from the infants under study, with a mean of 2.8
specimens per infant (range 1–25). Overall, 187 (25.9%) out of 722
subjects tested positive for MRSA. The mean interval of time
between admission and the first positive swab was 13.3 days
(median 7 days, IQR 5–16 days).
Table 2 summarizes the number of colonized MRSA patients
and the mean number of MRSA patient-days by year. This latter
Table 4. Comparison between characteristics at admission and during NICU stay of MRSA colonized and non colonized infants,
June 2009–June 2012, Palermo, Italy.
Variable Colonized (n=187) Noncolonized (n =535) P
At admission
Male gender, n (%) 88 (47.1) 321 (60.0) 0.001
Twin birth, n (%) 31 (16.6) 73 (13.6) 0.15
Malformation, n (%) 40 (21.4) 98 (18.3) 0.18
Inborn, n (%) 135 (72.2) 293 (54.8) ,0.001
Birth through vaginal delivery, n (%) 52 (27.8) 158 (29.5) 0.29
Admission to NICU $24 h after birth, n (%) 16 (8.6) 92 (17.2) 0.001
Apgar score at 5 min $8, n (%) 163 (87.2) 461 (86.2) 0.43
Gestational age, mean (SD), wk 36.4 (3.5) 36.7 (3.3) 0.23
Birth weight, mean (SD), g 2568 (867) 2673 (760) 0.12
During stay
Central venous access device, n (%) 51 (27.3) 192 (35.9) 0.01
Endotracheal tube, n (%) 37 (19.9) 114 (21.3) 0.33
Nasogastric tube, n (%) 71 (38.0) 201 (37.6) 0.47
nCPAP, n (%) 39 (20.9) 102 (19.1) 0.30
Parenteral nutrition, n (%) 80 (42.8) 270 (50.5) 0.07
Surgical procedure, n (%) 8 (4.3) 38 (7.1) 0.10
Formula feeding, n (%) 181 (96.8) 496 (92.7) 0.07
Breast milk feeding, n (%) 97 (51.9) 275 (51.4) 0.46
Length of stay, mean (SD), d 25.3 (30.9) 16.6 (16.7) 0.02
Ampicillin-sulbactam plus gentamicin, n (%) 73 (39.0) 266 (49.7) 0.005
Ampicillin-sulbactam plus gentamicin, mean (SD), d 4.8 (7.3) 5.0 (6.3) 0.36
Systemic antibacterial therapy, n (%) 83 (44.4) 297 (55.5) 0.004
Systemic antibacterial therapy, mean (SD), d 7.1 (14.2) 5.8 (9.1) 0.07
SD, standard deviation; nCPAP, nasal continuous positive airway pressure.
doi:10.1371/journal.pone.0087760.t004
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figure showed a value of 12.468.4 in the first year which declined
to 9.366.7 in the second year to climb again to 13.8610.9 during
the third year of study (ANOVA, F=3.58; Bonferroni test: 1st and
2nd year, P 0.23; 1st and 3rd year, P 0.98; 2nd and 3rd year, P
0.03). Consistently, the annual incidence density of acquisition of
MRSA over the three-year period ranged from a maximum of
20.2 cases for 1000 patient-days during the first year to a
minimum of 8.8 cases in the second one to raise again up to 13.1
cases during the third year. Incidence of clinical infections did not
significantly changed over the study period: it was 5.2 per 1000
patient-days in the first year, 6.5 per 1000 patient-days in the
second year and 4.9 per 1000 patient-days in the last year, P 0.48.
As Figure 1 illustrates, following the high prevalence rates
recorded in the first semester and the implementation of targeted
control strategies, the MRSA colonization prevalence decreased to
about 10%. However, a new dramatic rise occurred in the 8th to
10th quarters concurrently with the entry into the NICU of ST1-
MRSA-IVa and, soon afterwards, with a period of substantial
overcrowding. Indeed, through the entire period of observation a
mean of 70–95% beds had been used continuously, whereas in the
10th quarter the bed occupancy rate exceeded the standard of 16
beds by a mean of 15% in eight out of 13 weeks.
WCP ranged from 0% to 60.9% (mean 16.4611.6) over the
study period. The changes over time are summarized in Table 2.
Significant differences were observed between the first two years
(ANOVA, F=3.25; Bonferroni test: 1st and 2nd year, P 0.04; 1st
and 3rd year, P 0.76; 2nd and 3rd year, P 0.48). WCP significantly
correlated with the number of MRSA acquisitions in the following
week (correlation coefficient 0.77, P 0.009).
Characterization of MRSA Isolates
Overall, seven sequence types (STs) were identified, with ST22-
IVa being the predominant (166 out of 187, 88.8%). SCCmec type
IVa was identified in all MRSA isolates (Table 3). ST22-IVa
isolates were further subdivided by MLVF into eight different
subtypes. The largest number of isolates belonged to the MLVF
subtype ST22-A, which was detected through the entire period of
the study. Conversely, the detection of isolates belonging to the
two additional larger groups, i.e. ST22-IVa subtype 22-C and
ST1-IVa, was concentrated within more restricted intervals of
time (Figure 1 and Table 3).
As Table 3 illustrates, the MRSA isolates were fully susceptible
or, alternatively, resistant to a limited number of non-b lactam
antibiotics. In particular, none was resistant to sulfamethoxazole-
trimethoprim, tobramycin, linezolid, rifampicin, vancomycin and
teicoplanin. Only the ST1-IVa isolates showed an inducible
clindamycin resistant phenotype.
No isolate was found to carry the PVL gene sequence. The
DNA microarray profiling assigned the ST22 MRSA isolates to
the CC22-MRSA-IV tst1+, UK-EMRSA-15/ ‘‘Middle Eastern
Variant’’. These isolates were also negative for the sec and sel
genes. spa typing assigned them with type t223.
The isolates belonging to STs other than ST22 tested all
negative for tst1.
Table 5. Comparison between infants colonized by ST22-MRSA-IVa and those colonized by other genotypes, June 2009–June
2012, Palermo, Italy.
Variable
Infants with ST22-MRSA-IVa
colonization (n=166)
Infants with other MRSA
clones colonization (n=21) P
At admission
Male gender, n (%) 79 (47.6) 9 (42.9) 0.35
Twin birth, n (%) 28 (17.7) 3 (14.3) 0.37
Malformation, n (%) 98 (18.3) 40 (21.4) 0.18
Inborn, n (%) 35 (21.5) 5 (25.0) 0.35
Birth through vaginal delivery, n (%) 45/27.8) 7 (33.3) 0.30
Admission to NICU $24 h after birth, n (%) 11 (6.6) 5 (23.8) 0.02
Apgar score at 5 min $8, n (%) 146 (90.1) 17 (81.0) 0.18
Gestational age, mean (SD), wk 36.6 (3.3) 34.1 (4.1) 0.001
Birth weight, mean (SD), g 2604 (846) 2284 (996) 0.11
During stay
Surgical procedure, n (%) 5 (3.1) 3 (15.0) 0.04
Central venous access device, n (%) 39 (23.5) 12 (57.1) 0.001
Endotracheal tube, n (%) 29 (17.5) 8 (38.1) 0.03
Nasogastric tube, n (%) 60 (36.1) 11 (52.4) 0.08
nCPAP, n (%) 29 (17.5) 10 (47.6) 0.003
Parenteral nutrition, n (%) 64 (38.6) 16 (76.2) ,0.001
Length of stay, mean (SD), d 24.6 (31.1) 30.8 (28.9) 0.38
Ampicillin-sulbactam plus gentamicin, n (%) 61 (36.7) 12 (57.1) 0.05
Ampicillin-sulbactam plus gentamicin, mean (SD), d 4.0 (7.0) 7.8 (9.1) 0.03
Systemic antibacterial therapy, n (%) 69 (41.6) 14 (66.7) 0.02
Systemic antibacterial therapy, mean (SD), d 6.3 (13.0) 14.0 (20.7) 0.02
SD, standard deviation; nCPAP, nasal continuous positive airway pressure.
doi:10.1371/journal.pone.0087760.t005
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Characteristics of MRSA Colonized and Non Colonized
Infants
Demographic, clinical and healthcare related parameters of
MRSA colonized and non colonized infants are summarized in
Table 4. Compared with no colonization, the infants with MRSA
colonization were significantly more inborn than outborn.
Conversely, male gender and admission to NICU $24 h after
birth were negatively correlated with MRSA colonization
(Table 4). During the NICU stay, use of invasive devices was
not significantly different between the two groups of infants, except
for insertion of central venous catheters (CVCs) which was
significantly less frequent among those colonized with MRSA.
Administration of ampicillin-sulbactam plus gentamicin and, more
generally, of systemic antibacterial therapy, was significantly more
frequent among the non colonized neonates. Length of stay was
significantly longer for the colonized infants (Table 4). Neither
sepsis [colonized versus non colonized, 24 (12.8%) versus 49
(9.2%), P 0.09] nor in-hospital death [colonized versus non
colonized, 5 (2.7%) versus 8 (1.5%), P 0.30] were significantly
associated with MRSA colonization among the infants under
study.
When comparing the MRSA colonized neonates based upon
the MRSA strain, i.e. ST22-MRSA-IVa versus other MRSA
strains, the infants colonized by these latter ones were significantly
more likely to be admitted to NICU $24 h after birth and their
gestational age was significantly lower than those colonized with
the ST22 strain. Moreover, they were more frequently submitted
to surgery and exposed to invasive devices (Table 5). Antibacterial
treatment was also significantly more frequent and protracted in
this group of patients. (Table 5).
Sepsis [ST22 versus other MRSA colonized infants, 19 (11.4%)
versus 6 (28.6%), P0.04] was significantly associated with
colonization by other MRSA strains than ST22. Conversely, no
association was apparent with in-hospital death [ST22 versus
other MRSA strains, 4 (2.4%) versus 1 (4.8%), P 0.45].
Discussion
Neonates are highly susceptible to MRSA colonization.
Colonization and infection in NICU have been reported in many
countries and have been attributed to HA- or, with an increasing
frequency, to CA-MRSA strains [2]. MRSA can enter the NICU
via the family members of the neonates, the HCWs or the outborn
patients [15–18]. Blurring of boundaries between healthcare
settings and community is increasingly hindering an accurate
discrimination of HA- and CA-MRSA strains, when relying on
conventional epidemiology tools only [19].
Since 2000, in most European countries the epidemiology of
MRSA is evolving with a decreasing prevalence of multidrug
resistant MRSA clones and, conversely an increasing frequency of
non b-lactam susceptible clones. Among these latter clones, ST22-
IV (EMRSA-15] has a prominent role being one of the three most
frequent MRSA clones in seven out of 15 European countries [20–
21]. It is characteristically ciprofloxacin resistant and gentamicin
susceptible, rarely produces PVL, harbours SCCmec subtype IVh
and has spa type t022 or t032 or variants [21]. Fluoroquinolone
resistance appears to have played a key role in initiating pandemic
spread. However, the EMRSA clone ST22-IV has some further
properties which could explain its attitude to replace previously
well-established hospital associated strains, such as an increasing
biofilm production over time, the ability to maintain its growth
kinetics in presence of competitor clones and a more frequent
association with persistent bacteremia compared to other HA
clones [21,22]. A correlation between gentamicin susceptibility
and the enhanced ability of MRSA to survive and spread in
healthcare environments has been also reported [23]. A reason of
further concern is the tendency of ST22-IV to escape from the
healthcare environment to the community, which has been
described in highly endemic settings [19,24].
Our epidemiological landscape appears to be consistent with
this evolving trend. Indeed, a predominance of ST22-IV among
the non multiresistant isolates identified during 2009 in four
hospitals in Palermo, Italy, has been previously highlighted [25].
More recently, ST22-IVa was identified in eight out of 10 MRSA
carrying healthy children among a sample of 500 attending the
municipal child care centers of the same city [26]. However, our
ST22 isolates are distinctly different from the European pandemic
isolates. They, indeed, were identified as belonging to the tst1
positive, UK-EMRSA-15/ ‘‘Middle Eastern Variant’’ and were
also ciprofloxacin susceptible and sec and sel gene negative [27].
Moreover, they had a distinct spa type t223 and carried SCCmec
subtype a. Our ST22 variant seems to be identical to the ‘‘Gaza
strain’’ recently described by Biber A. et al. [28] as widely
spreading in community in the Gaza strip. Isolates with similar
characteristics have been also reported in Saudi Arabia, Abu
Dhabi and Egypt [27,29]. Moreover, isolation of tst1-positive
CC22-IV isolates has been described in England from patients of
apparent Middle Eastern origin and for the first time from a
sporadic case in USA [29]. Our data suggest that this clone is likely
more widely diffuse than it has been estimated and is spreading in
the Mediterranean area. Further investigations are necessary to
assess if this strain is a true HA clone, such as the classic EMRSA-
15, or, alternatively, a CA clone that might have entered the
NICU via the HCWs, the parents or the newborns. According
with Biber et al. [28], the relationship with local ST22-MSSA
strains could help answering this question. As previously reported,
MLVF was able to timely identify new circulating strains into the
NICU and to sub-cluster isolates belonging to the same ST and spa
type and endemically present in the ward [30].
At the beginning of our surveillance activity, the NICU proved
to be high-endemic for MRSA. A bundle of infection control
procedures was soon started which proved to be able to decrease
the colonization rate from more than 40% to approximately 10%
until the seventh quarter of the study period. The following sudden
rise in MRSA prevalence was attributed with the emergence and
spread of the CA-MRSA strain ST1-IVa followed by an epidemic
cluster of colonization cases by ST22-IVa [31]. Indeed, strength-
ening of the infection control procedures due to the alarm
generated by the entry in NICU of the gentamicin resistant ST1-
IVa strain proved to be effective in gaining eradication of this
strain, but unable to prevent a subsequent temporary recrudes-
cence of ST22-IV colonization. Many concurrent factors likely
contributed to this adverse outcome: the third year of study was,
indeed, characterized by a higher mean number of weekly patient-
days, a lower mean gestational age, a longer average length of stay
and a higher rate of outborn infants than the previous two years.
WCP also, following a significant decrease during the second year,
came back at the same value of the first year. Moreover, just
during the second quarter of the third year, NICU was
significantly crowded with an average bed occupancy rate
substantially exceeding the standard level. The concurrent
emergence and spread in NICU of a strain of carbapenemase
producing Klebsiella pneumoniae could have had a further adverse
impact on MRSA ST22-IVa transmission by distracting most
infection control efforts towards eradication of that organism [32].
Overcrowding is universally agreed as a major driving factor of
cross-transmission, mainly because of failure in adequately
performing hand hygiene procedures [2,5]. On the other hand,
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a high colonization pressure, i.e. .50%, can substantially hamper
effectiveness of infection control measures, including active
surveillance, and can require more aggressive control strategies
[33]. However, the rigorous application of infection control
policies and procedures was again successful in bringing MRSA
colonization prevalence rate back to about 10%.
In our experience, MRSA colonized and non colonized infants
did not differ except for a few characteristics. The inborn infants
were more likely to be MRSA colonized. This might reflect a
differential admission bias of parturients since the highest risk
pregnancies are more likely to be delivered in a maternity ward
with an annexed specialized NICU. On the contrary, non
colonized infants were more likely to be of male gender and later
admitted after birth than the colonized. Administration of a
systemic antibacterial drug therapy looked like to be more frequent
in non colonized infants, as a probable consequence of the
gentamicin susceptibility of the predominant MRSA clone.
Literature is not quite unanimous about risk factors for coloniza-
tion by MRSA strains in NICU patients and an association
between MRSA acquisition and the most reputed determinants,
such as gestational age, birth weight, presence of underlying
disease, CVCs or previous treatment with antibiotics is not always
reported [4]. Moreover, colonization pressure in high endemic
settings is expected to accelerate MRSA acquisition regardless of
the risk factors and, consequently, to level out the differences
between colonized and non colonized infants. However, many
variables commonly associated with nosocomial acquisition of
MRSA, such as lower gestational age, more frequent use of
invasive devices and administration of antibiotics, proved to be
more likely associated with infants colonized by MRSA strains
other than ST22-IV. Moreover, while no significant differences
were detected in frequency of sepsis and in-hospital death between
MRSA colonized and non colonized infants, infants colonized
with non ST22 strains were significantly more likely to develop
sepsis. Of interest, the majority of the non ST22 strains were ST1,
a typical CA-MRSA clone, which has been responsible for an
epidemic spread following its importation into the NICU via an
infected infant from another healthcare facility [31].
MRSA spread in NICU has been reported to be difficult to
control [34–38], due also to its possible (re)introduction from
different sources over time. Only implementation of aggressive
infection control measures, frequently combined with mupirocin
treatment of infants and HCWs and, more recently, chlorhexidine
gluconate body wash of colonized infants, has proved to be
successful in controlling some outbreaks [35,39]. However, poor
success of mupirocin decolonization has also been reported,
mainly in association with MRSA colonization of body sites other
than nares [40]. Moreover, besides the issue of the possible
selection of mupirocin resistant strains, there are safety concerns
regarding usage of decolonizing agents in preterm infants and
newborns [40]. A further issue of concern is the possible selection
of non susceptible Gram negatives which may colonize patients
after chlorexidine application or, more insidiously, contaminate
disinfectant products [41]. More generally, data supporting cost-
effectiveness of NICU specific infection control strategies are
limited and further studies are warranted.
During the three-year period of surveillance, we registered a
considerable decrease of the prevalence of MRSA colonization in
NICU, from 41% to 9%, a favourable trend which was transiently
interrupted by the introduction of the ST1-IVa strain and a
recrudescence of colonization by ST22-IVa, as above discussed. A
multifaceted infection control intervention was implemented and is
still in place, except for screening and decolonization of HCWs.
Since all the measures were undertaken simultaneously, it is
impossible to define which of the measures was the most effective.
However, they were unable to definitively eradicate MRSA from
the NICU. This partial failure can supposedly result from many
concurrent factors, such as periodic overcrowding and relative
understaffing, the peculiar case-mix of patients in our NICU,
possible recurrent introductions of MRSA from community
through parents or HCWs, failure to strictly adhere to recom-
mended practices for long periods and the relative ineffectiveness
of routine procedures in controlling strains with a high fitness in
the hospital setting, such as ST22 [22,23]. The peculiar
susceptibility of newborns and their frequent contacts with possible
carrier adults further contribute to the MRSA persistence.
Our study has some limitations. It was performed in a single
NICU in an university affiliated general hospital, which is also a
reference center for genetic diseases. This can limit generalizability
of the results. Screening of newborns at admission was only
performed during the first six months of the study, as well as
screening of HCWs. So, timing of MRSA acquisition in NICU was
not traceable and assessment of risk factors was not feasible.
Moreover, screening of parents and family members was not
performed at all. In summary, our MRSA surveillance program
did not include active efforts aimed to identify sources of MRSA
other than the infants. Along with the limited epidemiological data
about community MRSA carriage in our geographic area, some
gaps in our surveillance system do not allow understanding the
dynamics of MRSA introduction in the NICU. Moreover,
continuous quantitative data regarding nurse-to-patient ratio and
adherence of staff to infection control procedures, such as hand
washing, were not collected.
Conclusions
This is the first study to provide prospective baseline data on the
prevalence of MRSA in our NICU. Furthermore, the molecular
characterization has shown to be valuable to detect the emergence
and spread of the various circulating clones. However, surveillance
data from other hospitals who admit patients to our NICU or from
the community could be helpful in elucidating most probable
routes of MRSA entry into the NICU.
The NICU is a complex ecosystem, where interactions between
pre-admission factors, both maternal and infant-related, MRSA
strain factors and healthcare setting factors, including patient
management and contacts with the staff, are a continuous
challenge for infection control. In our experience, an endemic
presence of ST22-MRSA-IVa was accompanied by the introduc-
tion of multiple MRSA strains which sporadically or epidemically
colonized NICU infants. Unlike clinical cultures which would have
seriously underestimated affected neonates, active surveillance
contributed to obtain a reliable picture of the MRSA dissemina-
tion in NICU. Risk factors for MRSA colonization in NICU
infants as well as impact of organizational and structural issues
deserve further studies in different settings with various levels of
endemicity and different patterns of circulating strains.
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